Search results
Showing 4891 to 4905 of 5739 results for technology
This advice has been updated and replaced by NICE medical technologies guidance 47.
This advice has been updated and replaced by NICE medical technologies guidance 42.
PneuX for preventing ventilator-associated pneumonia in intensive care (MIB45)
This advice has been updated and replaced by NICE medical technologies guidance 48.
This guideline covers contraceptive services for under-25s. It aims to ensure all under-25s are given advice and information on all types of contraception. This includes additional tailored support to meet the particular needs and choices of those who are socially disadvantaged or who may find it difficult to use these services.
View recommendations for PH51Show all sections
This guidance has been updated and replaced by NICE highly specialised technologies guidance 22.
myCOPD for self-management of chronic obstructive pulmonary disease (MIB214)
This advice has been updated and replaced by NICE medical technologies guidance 68.
Asfotase alfa for treating paediatric-onset hypophosphatasia (HST6)
This guidance has been updated and replaced by NICE highly specialised technologies guidance 23.
This medical technologies guidance has been replaced by the recommendation on cardiac output monitoring in the NICE guideline on perioperative care in adults.
Elosulfase alfa for treating mucopolysaccharidosis type IVa (HST2)
This guidance has been updated and replaced by NICE’s highly specialised technologies guidance on elosulfase alfa for treating mucopolysaccharidosis type 4A (HST19).
Self-harm: assessment, management and preventing recurrence (NG225)
This guideline covers assessment, management and preventing recurrence for children, young people and adults who have self-harmed. It includes those with a mental health problem, neurodevelopmental disorder or learning disability and applies to all sectors that work with people who have self-harmed.
Irreversible electroporation for treating prostate cancer (IPG768)
We have moved interventional procedures guidance 768 to become HealthTech guidance 688. This is to better reflect the NICE HealthTech programme which combines the former NICE Diagnostics Assessment programme, Interventional Procedures programme and Medical Technologies Evaluation programme and to help you find relevant content more quickly. The guidance itself has not changed.
Transcatheter aortic valve implantation (TAVI) for native aortic valve regurgitation (IPG805)
We have moved interventional procedures guidance 805 to become HealthTech guidance 752. This is to better reflect the NICE HealthTech programme which combines the former NICE Diagnostics Assessment programme, Interventional Procedures programme and Medical Technologies Evaluation programme and to help you find relevant content more quickly. The guidance itself has not changed.
We have moved interventional procedures guidance 796 to become HealthTech guidance 733. This is to better reflect the NICE HealthTech programme which combines the former NICE Diagnostics Assessment programme, Interventional Procedures programme and Medical Technologies Evaluation programme and to help you find relevant content more quickly. The guidance itself has not changed.
MRI-guided focused ultrasound subthalamotomy for treating Parkinson's (IPG797)
We have moved interventional procedures guidance 797 to become HealthTech guidance 734. This is to better reflect the NICE HealthTech programme which combines the former NICE Diagnostics Assessment programme, Interventional Procedures programme and Medical Technologies Evaluation programme and to help you find relevant content more quickly. The guidance itself has not changed.
We have moved interventional procedures guidance 806 to become HealthTech guidance 755. This is to better reflect the NICE HealthTech programme which combines the former NICE Diagnostics Assessment programme, Interventional Procedures programme and Medical Technologies Evaluation programme and to help you find relevant content more quickly. The guidance itself has not changed.